Zachary H. Houston

Zachary H. Houston

Auto-generated profile, based on publicly available information

Zachary H. Houston

Centre for Advanced Imaging and Australian Institute for Bioengineering and Nanotechnology, The University of Queensland, Brisbane, QLD, 4072, Australia

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 May 2018 in ACS Central Science
Verified
Journal Article
Open access
LBLewis D. Blackman
Lewis D. Blackman
Spyridon VarlasSpyridon Varlas
Spyridon Varlas
MAMaria Chiara Arno
Maria Chiara Arno
ZHZachary H. Houston
Zachary H. Houston
NFNicholas Fletcher
Nicholas Fletcher
RORachel O'reilly
Rachel O'reilly
Covalent PEGylation of biologics has been widely employed to reduce immunogenicity, while improving stability and half-life in vivo. This approach requires covalent protein modification, creating a new entity. An alternative approach is stabilization by encapsulation into polymersomes; however this typically requires multiple steps, and the segregation requires the vesicles to be permeable to retain function. Herein, we demonstrate the one-pot synthesis of therapeutic enzyme-loaded vesicles with size-selective permeability using polymerization-induced self-assembly (PISA) enabling the encapsulated enzyme to function from within a confined domain. This strategy increased the proteolytic stability and reduced antibody recognition compared to the free protein or a PEGylated conjugate, thereby reducing potential dose frequency and the risk of immune response. Finally, the efficacy of encapsulated l-asparaginase (clinically used for leukemia treatment) against a cancer line was demonstrated, and its biodistribution and circulation behavior in vivo was compared to the free enzyme, highlighting this methodology as an attractive alternative to the covalent PEGylation of enzymes.

20 December 2012 in Organic & Biomolecular Chemistry
Verified
Journal Article
Closed access
PDF file
LGLalit N. Goswami
Lalit N. Goswami
ZHZachary H. Houston
Zachary H. Houston
SSSaurav J. Sarma
Saurav J. Sarma
SJSatish S. Jalisatgi
Satish S. Jalisatgi
MHM. Frederick Hawthorne
M. Frederick Hawthorne
Herein we describe the sequential synthesis of a variety of azide-alkyne click chemistry-compatible heterobifunctional oligo(ethylene glycol) (OEG) linkers for bioconjugation chemistry applications. Synthesis of these bioorthogonal linkers was accomplished through desymmetrization of OEGs by conversion of one of the hydroxyl groups to either an alkyne or azido functionality. The remaining distal hydroxyl group on the OEGs was activated by either a 4-nitrophenyl carbonate or a mesylate (–OMs) group. The –OMs functional group served as a useful precursor to form a variety of heterobifunctionalized OEG linkers containing different highly reactive end groups, e.g., iodo, –NH2, –SH and maleimido, that were orthogonal to the alkyne or azido functional group. Also, the alkyne- and azide-terminated OEGs are useful for generating larger discrete poly(ethylene glycol) (PEG) linkers (e.g., PEG16 and PEG24) by employing a Cu(I)-catalyzed 1,3-dipolar cycloaddition click reaction. The utility of these clickable heterobifunctional OEGs in bioconjugation chemistry was demonstrated by attachment of the integrin (αvβ3) receptor targeting peptide, cyclo-(Arg-Gly-Asp-D-Phe-Lys) (cRGfKD) and to the fluorescent probe sulfo-rhodamine B. The synthetic methodology presented herein is suitable for the large scale production of several novel heterobifunctionalized OEGs from readily available and inexpensive starting materials.

1 October 2017 in Biomaterials
Verified
Journal Article
Closed access
APAmanda K Pearce
Amanda K Pearce
JSJoshua Simpson
Joshua Simpson
NFNicholas Fletcher
Nicholas Fletcher
ZHZachary H. Houston
Zachary H. Houston
AFAdrian V. Fuchs
Adrian V. Fuchs
Kris ThurechtKris Thurecht
Kris Thurecht

10 June 2016 in Advanced Healthcare Materials
Verified
Journal Article
Closed access
PDF file
CHChristopher B. Howard
Christopher B. Howard
NFNicholas Fletcher
Nicholas Fletcher
ZHZachary H. Houston
Zachary H. Houston
AFAdrian V. Fuchs
Adrian V. Fuchs
NBNathan R. B. Boase
Nathan R. B. Boase
Kris ThurechtKris Thurecht
Kris Thurecht

7 September 2017 in Molecular Pharmaceutics
Verified
Journal Article
Closed access
YZYongmei Zhao
Yongmei Zhao
ZHZachary H. Houston
Zachary H. Houston
JSJoshua Simpson
Joshua Simpson
LCLiyu Chen
Liyu Chen
NFNicholas Fletcher
Nicholas Fletcher
Kris ThurechtKris Thurecht
Kris Thurecht

28 April 2020 in ACS Central Science
Verified
Journal Article
Closed access
ZHZachary H. Houston
Zachary H. Houston
JBJens Bunt
Jens Bunt
KCKok-Siong Chen
Kok-Siong Chen
SPSimon Puttick
Simon Puttick
CHChristopher B. Howard
Christopher B. Howard
Kris ThurechtKris Thurecht
Kris Thurecht